Curium Group, PeptiDream & PDRadiopharma begin patient enrollment in registrational clinical trial of 64Cu-PSMA-I&T for prostate cancer in Japan: Paris, France Friday, October 17, ...

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights: San Diego Friday, October 17, 2025, 17:00 Hrs [IST] Illu ...

Biorad Medisys accelerates vascular and stroke care through new partnerships and technology: Our Bureau, Mumbai Friday, October 17, 2025, 16:15 Hrs [IST] Biorad Medisys Pvt. Ltd.

AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme: United Kingdom Friday, October 17, 2025, 16:00 Hrs [IST] Artificial int ...

SK bioscience files for first-in-human trial of universal coronavirus vaccine, GBP511 phase 1/2 study in Australia: Republic of Korea Friday, October 17, 2025, 15:00 Hrs [IST] SK ...

The treatment group showed significant improvements in key clinical and metabolic biomarkers from the third day of therapy, suggesting that this technique may represent a promising adjunctive approach ...

Suraksha Clinic and Diagnostics conducts East Zone AMBI workshop on capillary electrophoresis and immunotyping: Our Bureau, Mumbai Friday, October 17, 2025, 13:45 Hrs [IST] Suraks ...

Chemist Lutz Ackermann receives Bayer Foundation’s Hansen Family Award: Leverkusen Friday, October 17, 2025, 13:00 Hrs [IST] ...

Roche presents major advances for its sequencing by expansion technology, including a new Guinness World Record, at the ASHG conference 2025: Basel Friday, October 17, 2025, 12:00 ...

Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals: Our Bureau, Mumbai Friday, October 17, 2025, 10:45 Hrs [IST] Marengo Asia Hospitals, a multi-s ...

Novartis Fabhalta meets phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy: Basel Friday, October 17, 2025, 10:00 Hrs [IST] Novartis announ ...